Related Experiment Video
Updated: Oct 16, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis
Yuhao Zou1,2, Chenming Zhong2, Zekai Hu2
1Institute of Translational Medicine, Zhejiang University City College, Hangzhou, China.
Abstract:
miR-873 is a microRNA located on chromosome 9p21.1. miR-873-5p and miR-873-3p are the two main members of the miR-873 family. Most studies focus on miR-873-5p, and there are a few studies on miR-873-3p. The expression level of miR-873-5p was down-regulated in 14 cancers and up-regulated in 4 cancers. miR-873-5p has many targeted genes, which have unique molecular functions such as catalytic activity, transcription regulation, and binding. miR-873-5p affects cancer development through the PIK3/AKT/mTOR, Wnt/β-Catenin, NF-κβ, and MEK/ERK signaling pathways. In addition, the target genes of miR-873-5p are closely related to the proliferation, apoptosis, migration, invasion, cell cycle, cell stemness, and glycolysis of cancer cells. The target genes of miR-873-5p are also related to the efficacy of several anti-cancer drugs. Currently, in cancer, the expression of miR-873-5p is regulated by a variety of epigenetic factors. This review summarizes the role and mechanism of miR-873-5p in human tumors shows the potential value of miR-873-5p as a molecular marker for cancer diagnosis and prognosis.
Insights
MicroRNA-873-5p (miR-873-5p) plays a key role in various cancers, impacting tumor development and drug efficacy. Its dysregulation and molecular functions highlight its potential as a diagnostic and prognostic cancer marker.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNA-873 (miR-873) is a microRNA located on chromosome 9p21.1, with miR-873-5p and miR-873-3p as its main members.
- While miR-873-5p is the focus of most research, miR-873-3p has received less attention.
- miR-873-5p expression is altered in numerous cancers, being down-regulated in 14 and up-regulated in 4 types.
Purpose of the Study:
- To review the role and mechanisms of miR-873-5p in human tumors.
- To explore the potential of miR-873-5p as a molecular marker for cancer diagnosis and prognosis.
Main Methods:
- Literature review summarizing existing studies on miR-873-5p in cancer.
- Analysis of miR-873-5p's targeted genes and their molecular functions.
- Investigation of miR-873-5p's involvement in key cancer-related signaling pathways.
Main Results:
- miR-873-5p targets genes involved in catalytic activity, transcription regulation, and binding.
- It influences cancer development via PIK3/AKT/mTOR, Wnt/β-Catenin, NF-κβ, and MEK/ERK pathways.
- Target genes are linked to cancer cell proliferation, apoptosis, migration, invasion, cell cycle, stemness, and glycolysis.
- miR-873-5p affects anti-cancer drug efficacy and its expression is epigenetically regulated.
Conclusions:
- miR-873-5p is a significant factor in human tumorigenesis.
- Its multifaceted roles suggest potential as a biomarker for cancer diagnosis and prognosis.
- Further research into miR-873-5p mechanisms could lead to novel therapeutic strategies.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017